MST1R-targeted therapy in the battle against gallbladder cancer
Overall, targeting MST1R and its downstream genes, particularly combining MGCD-265 with SKLB325, holds promise as a therapeutic strategy for GBC.
Authors
- Puxiongzhi Wang
- Chao Huang (ORCID: https://orcid.org/0000-0002-4913-921X)
- Yangming Liu (ORCID: https://orcid.org/0009-0002-0742-9216)
- Li‐Qin Yu (ORCID: https://orcid.org/0000-0003-2211-567X)
- Rongmu Xia
- Li Zhang (ORCID: https://orcid.org/0000-0002-6774-2733)
- Wei Wang (ORCID: https://orcid.org/0000-0003-1568-222X)
Institutions
- Kunming University of Science and Technology (CN)
- Fujian University of Traditional Chinese Medicine (CN)
- Shanghai Jiao Tong University (CN)
- Shanghai Sixth People's Hospital (CN)
Publication Details
- Journal
- Cell & Bioscience
- Published
- 2024-08-29
- DOI
- https://doi.org/10.1186/s13578-024-01290-w
- Citations
- 1
- Primary Topic
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.57
Funders
- National Natural Science Foundation of China